Nigeria Has Utilized 88% Of Total COVID-19 Vaccines In Stock - NPHCDA
It has been reported that Nigeria has utilised over 3.4 million doses of Oxford AstraZeneca COVID-19 vaccine for both the 1st and 2nd vaccination rounds and this has amounted to approximately 88 per cent of the total COVID-19 vaccine stock in the country. The Executive Director, National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib during a national briefing of the COVID-19 Presidential Steering Committee on Monday further disclosed that “a total of 4,024,000 doses of Oxford/AstraZeneca vaccine were received by the Federal Government of Nigeria in March 2021".